Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Gowling WLG (Canada) LLP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Gowling WLG (Canada) LLP

arrow
ChemOutsourcing
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
ChemOutsourcing
Not Confirmed

GALCANEZUMAB

Brand Name : EMGALITY

Patent Number : 2802102

Filing Date : 2011-06-07

Strength per Unit : 120 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2031-06-07

Date Granted : 2016-07-26

blank

02

Gowling WLG (Canada) LLP

arrow
ChemOutsourcing
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
ChemOutsourcing
Not Confirmed

GALCANEZUMAB

Brand Name : EMGALITY

Patent Number : 2802102

Filing Date : 2011-06-07

Strength per Unit : 120 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2031-06-07

Date Granted : 2016-07-26

blank

03

Gowling WLG (Canada) LLP

arrow
ChemOutsourcing
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
ChemOutsourcing
Not Confirmed

GALCANEZUMAB

Brand Name : EMGALITY

Patent Number : 2802102

Filing Date : 2011-06-07

Strength per Unit : 100 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2031-06-07

Date Granted : 2016-07-26

blank